Invention Grant
- Patent Title: Immunoreactive glycoprotein GP19 Ehrlichia canis
-
Application No.: US12377926Application Date: 2007-08-07
-
Publication No.: US09605032B2Publication Date: 2017-03-28
- Inventor: Jere W. McBride , Christopher K. Doyle
- Applicant: Jere W. McBride , Christopher K. Doyle
- Applicant Address: US NV Carson City
- Assignee: Research Development Foundation
- Current Assignee: Research Development Foundation
- Current Assignee Address: US NV Carson City
- Agency: Parker Highlander PLLC
- International Application: PCT/US2007/075343 WO 20070807
- International Announcement: WO2008/112007 WO 20080918
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K14/00 ; C07K7/08 ; A61K38/10 ; C07K16/00 ; A61K38/00 ; A61K39/395 ; A61K39/44 ; C07K14/195 ; C07K16/12 ; G01N33/569
Abstract:
The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
Public/Granted literature
- US20100330091A1 IMMUNOREACTIVE GLYCOPROTEIN GP19 EHRLICHIA CANIS Public/Granted day:2010-12-30
Information query
